Author details:
Simple Summary: The low pathogenic avian influenza H9N2 virus has been associated with severe economic losses in broiler chicken flocks. Problems associated with its control strategy are potential early infection and level of immune response that may be high in one-day-old chicks due to maternally derived antibodies. Herein, two vaccination regimes were evaluated in commercial broilers kept under either field or laboratory conditions. Two different vaccine types and concentrations were used, and the results highlighted a significantly higher protection against early infection when a homologous vaccine of high antigenic mass was applied at 7 days of life. Shedding was significantly reduced in this regime.
Abstract: Low pathogenic avian influenza virus is one of the major threats that has been affecting the poultry industry in the Middle East region for decades. Attempts to eradicate this disease have failed. Currently, there are commercial vaccines that are either imported or produced locally from recently circulating isolates of H9N2 in Egypt and Middle Eastern countries. This present work focused on comparing the effectiveness of two vaccines belonging to these categories in Egypt. Two commercial broiler flocks (Cobb-500 Broiler) with maternally derived immunity (MDA) against H9N2 virus were employed and placed under normal commercial field conditions or laboratory conditions. Immunity was evaluated on the basis of detectable humoral antibodies against influenza H9N2 virus, and challenge was conducted at 28 days of life using a recent wild H9N2 virus. The results showed that vaccination on the 7th day of life provided significantly higher immune response in both vaccine types, with significantly lower virus shedding compared to vaccination at day 1 of life, regardless of field or laboratory conditions. In addition, the vaccine produced from a recent local H9N2 isolate (MEFLUVAC-H9-16) provided a significantly higher humoral immune response under both field and laboratory conditions, as measured by serology and virus shedding (number of shedders and amount of shedding virus), being significantly lower following challenge on the 28th day of life, contrary to the imported H9 vaccine. In conclusion, use of H9N2 vaccine at 7 days of life provided a significantly higher protection than vaccination at day 1 of life in birds with MDA, suggesting vaccination regimes between 5–8-days of life for broiler chicks with MDA. Moreover, use of a vaccine prepared from a recently circulating H9N2 virus showed significantly higher protection and was more suitable for birds in the Middle East.
Keywords: avian influenza; homologous vaccine; heterologous vaccine; broiler; early infection.
1. Dia, M.S.; Hafez, M.S.A.E.; Ashry, M.A.; Elfeil, W.K. Occurrence of avian influenza h5n1 among chicken,
duck farms and human in Egypt. Am. J. Anim. Vet. Sci. 2019, 14, 26–32. [CrossRef]
2. Eid, H.M.; Algammal, A.M.; Elfeil, W.K.; Youssef, F.M.; Harb, S.M.; Abd-Allah, E.M. Prevalence, molecular
typing, and antimicrobial resistance of bacterial pathogens isolated from ducks. Vet. World 2019, 12, 677–683.
[CrossRef]
3. Sedeik, M.E.; Awad, A.M.; Rashed, H.; Elfeil, W.K. Variations in Pathogenicity and Molecular Characterization
of Infectious Bursal Disease Virus (IBDV) in Egypt. Am. J. Anim. Vet. Sci. 2018, 13, 76–86. [CrossRef]
4. Eid, H.I.; Algammal, A.M.; Nasef, S.A.; Elfeil, W.K.; Mansour, G.H. Genetic variation among avian pathogenic
E. coli strains isolated from broiler chickens. Asian J. Anim. Vet. Adv. 2016, 11, 350–356. [CrossRef]
5. Ayoub, M.A.; Elfeil, W.K.; El Boraey, D.; Hammam, H.; Nossair, M.A. Evaluation of some vaccination
programs in protection of experimentally challenged broiler chicken against newcastle disease virus. Am. J.
Anim. Vet. Sci. 2019, 14, 197–206. [CrossRef]
6. Sultan, H.A.; Talaat, S.; Elfeil, W.K.; Selim, K.; Kutkat, M.A.; Amer, S.A.; Choi, K.S. Protective efficacy of the
Newcastle disease virus genotype VII–matched vaccine in commercial layers. Poult. Sci. 2020, 99, 1275–1286.
[CrossRef] [PubMed]
7. Elfeil, W.K.; Ezzat, M.E.; Fathi, A.; Alkilany, M.-A.A.; Abouelmaatti, R.R. Prevalence and Genotypic Analysis
and Antibiotic Resistance of Salmonella Species Isolated from Imported and Freshly Slaughtered Chicken.
Am. J. Anim. Vet. Sci. 2020, 15, 134–144. [CrossRef]
8. Fawzy, M.; Ali, R.; Elfeil, W.; Saleh, A.; Eltarabilli, M. Efficacy of inactivated velogenic Newcastle disease
virus genotype VII vaccine in broiler chickens. Vet. Res. Forum 2020, 11, 113–120. [CrossRef] [PubMed]
9. Sultan, H.A.; Ali, A.; El Feil, W.K.; Bazid, A.H.I.; Zain El-Abideen, M.A.; Kilany, W.H. Protective Efficacy
of Different Live Attenuated Infectious Bronchitis Virus Vaccination Regimes against Challenge with IBV
Variant-2 Circulating in the Middle East. Front. Vet. Sci. 2019, 6, 341. [CrossRef] [PubMed]
10. Rady, M.; Ezz-El-Din, N.; Mohamed, K.F.; Nasef, S.; Samir, A.; Elfeil, W.K. Correlation between ESβL Salmonella
Serovars Isolated from Broilers and their Virulence Genes. J. Hell. Vet. Med Soc. 2020, 71, 2163–2170. [CrossRef]
11. Capua, I. Avian Influenza and Newcastle Disease: A Field and Laboratory Manual; Springer: Milan, Italy, 2009.
12. Swayne, D.E.; Glisson, J.R. Diseases of Poultry; Wiley-Blackwell: Ames, Iowa, 2013.
13. Abouelmaatti, R.R.; Algammal, A.M.; Li, X.; Ma, J.; Abdelnaby, E.A.; Elfeil, W.M.K. Cloning and analysis of
Nile tilapia Toll-like receptors type-3 mRNA. Cent. Eur. J. Immunol. 2013, 38, 277–282. [CrossRef]
14. Elfeil, W.K.; Abouelmaatti, R.R.; Sun, C.; Han, W.; Li, X.; Ma, J.; Lei, L.; Liu, S.; Yang, Y.; Wang, Y.; et al.
Identification, cloning, expression of a novel functional anasplatyrhynchos mRNA TLR4. J. Anim. Vet. Adv.
2012, 11, 1727–1733. [CrossRef]
15. Elfeil, W.M.K.; Algammal, A.M.; Abouelmaatti, R.R.; Gerdouh, A.; Abdel-Daim, M.M. Molecular characterization
and analysis of TLR-1 in rabbit tissues. Cent. Eur. J. Immunol. 2016, 41, 236–242. [CrossRef] [PubMed]
16. Abouelmaatti, R.R.; Algammal, A.M.; Elfeil, W.M.K.; Elshaffy, N.M.; Li, X.; Ma, J.; Fawzy, M.; Wahdan, A.;
El-Tarabili, R.; Shabana, I.I. Genetic characterization, cloning, and expression of Toll-like Receptor 1 mRNA
Oreochromis niloticus. Vet. Arh. 2020, 90, 193–204. [CrossRef]
17. Capua, I.; Alexander, D.J. Avian influenza: Recent developments. Avian Pathol. 2004, 33, 393–404. [CrossRef]
18. Spackman, E. Avian Influenza Virus; Humana Press: Totowa, NJ, USA, 2008; Volume 436.
19. El-Zoghby, E.F.; Arafa, A.S.; Hassan, M.K.; Aly, M.M.; Selim, A.; Kilany, W.H.; Selim, U.; Nasef, S.; Aggor, M.G.;
Abdelwhab, E.M.; et al. Isolation of H9N2 avian influenza virus from bobwhite quail (Colinus virginianus) in
Egypt. Arch. Virol. 2012, 157, 1167–1172. [CrossRef]
20. Monne, I.; Hussein, H.A.; Fusaro, A.; Valastro, V.; Hamoud, M.M.; Khalefa, R.A.; Dardir, S.N.; Radwan, M.I.;
Capua, I.; Cattoli, G. H9N2 influenza A virus circulates in H5N1 endemically infected poultry population in
Egypt. Influenza Other Respir. Viruses 2013, 7, 240–243. [CrossRef]
21. El Sayed, M.; Alyousef, Y.; Al Sayed, A.; Elfeil, W. Evaluation of the antibody response of two local Saudi
lines and commercial chickens vaccinated against newcastle diseases virus and infectious bursal disease
virus. Sci. J. King Faisal Univ. 2019, 20, 105–113.
22. Gharaibeh, S. Pathogenicity of an Avian Influenza Virus Serotype H9N2 in Chickens. Avian Dis. 2008, 52,
106–110. [CrossRef]
23. Hsu, S.M.; Chen, T.H.H.; Wang, C.H. Efficacy of Avian Influenza Vaccine in Poultry: A Meta-analysis. Avian
Dis. 2010, 54, 1197–1209. [CrossRef]
24. Ahad, A.; Thornton, R.N.; Rabbani, M.; Yaqub, T.; Younus, M.; Muhammad, K.; Mahmood, A.; Shabbir, M.Z.;
Kashem, M.A.; Islam, M.Z. Risk factors for H7 and H9 infection in commercial poultry farm workers in
provinces within Pakistan. Prev. Vet. Med. 2014, 117, 610–614. [CrossRef] [PubMed]
25. Qiang, F.; Youxiang, D. The effects of H9N2 influenza A on the immune system of broiler chickens in the
Shandong Province. Transbound. Emerg. Dis. 2011, 58, 145–151. [CrossRef] [PubMed]
26. Farzin, H.; Toroghi, R.; Haghparast, A. Up-regulation of pro-inflammatory cytokines and chemokine
production in avian influenza H9N2 virus-infected human lung epithelial cell line (A549). Immunol. Investig.
2016, 45, 116–129. [CrossRef] [PubMed]
27. Arafat, N.; Eladl, A.H.; Marghani, B.H.; Saif, M.A.; El-shafei, R.A. Enhanced infection of avian influenza virus
H9N2 with infectious laryngeotracheitis vaccination in chickens. Vet. Microbiol. 2018, 219, 8–16. [CrossRef]
28. Bonfante, F.; Cattoli, G.; Leardini, S.; Salomoni, A.; Mazzetto, E.; Davidson, I.; Haddas, R.; Terregino, C.
Synergy or interference of a H9N2 avian influenza virus with a velogenic Newcastle disease virus in chickens
is dose dependent. Avian Pathol. 2017, 46, 488–496. [CrossRef]
29. Nagy, A.; Mettenleiter, T.C.; Abdelwhab, E.M. A brief summary of the epidemiology and genetic relatedness
of avian influenza H9N2 virus in birds and mammals in the Middle East and North Africa. Epidemiol. Infect.
2017, 145, 3320–3333. [CrossRef]
30. Sultan, A.H.; Abd El-Razik, G.A.; Allam, S.T.; El-Deeb, A.H. Inactivated oil emulsion H9N2 vaccine in broiler
chickens: Pathogenesis and Clinicopathological studies. Am. J. Res. Commun. 2015, 3, 38–53.
31. Elfeil, W.; Abouelmaatti, R.; Diab, M.; Mandour, M.; Rady, M. Experimental Infection of Chickens by Avian
Influenza H9N2 Virus: Monitoring of Tissue Tropism and Pathogenicity. J. Egypt. Vet. Med. Assoc 2018, 78,
369–383.
32. OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals-Avian Influenza. In OIE Terrestrial
Manual 2015; OIE: Rome, Italy, 2015.
33. Nolan, T.; Hands, R.E.; Bustin, S.A. Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 2006, 1,
1559. [CrossRef]
34. Steel, R.G.D.; Torrie, J.H. Principles and Procedures of Statics; Mcgraw Hill Book Comp. Inc.: London, UK, 1960.
35. Kilany, W.; Bazid, A.-H.; Ali, A.; El-Deeb, A.; Zain El Abideen, M.; Sayed, M.; El-Kady, M. Comparative
Effectiveness of Two Oil Adjuvant–Inactivated Avian Influenza H9N2 Vaccines. Avian Dis. 2016, 60, 226–231.
[CrossRef]
36. Khalil, A.; Hussein, H.; Tolba, S.; El-Sanousi, A. Preparation and Evaluation of H9n2 Vaccine Adjuvated with
Montanide ISA71 VG. Glob. Vet. 2015, 15, 670–674. [CrossRef]
37. Elfeil, W.K.; Abouelmaatti, R.R.; Ibrahim, H.H.; Ali, A.; Kilany, W.H.; Rady, A.; El-Sayed, M. Comparison of
the effectiveness of two local and imported inactivated combined H9N2-ND vaccines in broiler flocks in
Egypt. In Proceedings of the IX International Veterinary Conference: One World, One Health, Sharm El
Sheikh City, Egypt, 9–13 March 2009.
38. El-Deeb, A.H.; Kilany, W.; Hanafie, A.; Echeverry, F.; El-Kady, M. Comparative Field Evaluation of Protective
Efficacy of Commercially Available H9N2 Vaccines in Breeders in Egypt. In Proceedings of the 19th World
Veterinary Poultry Association Congress, Cape Town, South Africa, 7–11 September 2015.
39. Elfeil, W.; Hanfie, A.; Rady, M.; Kilany, W.; Ibrahim, H.; Elkady, M.; Elsayed, M. Evaluation of Different H9N2
vaccination regime in commercial Broiler breeders flocks. In Proceedings of the XX World Veterinary Poultry
Association Congress, Edinburgh International Conference Centre (EICC), Edinburgh, UK, 2 May 2017.
40. Kilany, W.; Ali, A.; Bazid, A.-H.; El-Deeb, A.; Zain El Abideen, M.; Sayed, M.; El-Kady, M. A Dose-Response
Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial
Broiler Chickens. Avian Dis. 2016, 60, 256–261. [CrossRef] [PubMed]
41. Elfeil,W.; Yousef, H.; Fawzy,M.; Ali, A.; Kilany,W.; Ibrahim, H.; Elsayed,M. Protective efficacy ofMEFLUVAC H9
in turkey poults in both lab and Field condition. In Proceedings of the XXIst World Veterinary Poultry Association
Congress, Angkok International Trade and Exhibition Centre, Bangkok, Thailand, 16–20 September 2019.
42. Sun, Y.; Pu, J.; Fan, L.; Sun, H.; Wang, J.; Zhang, Y.; Liu, L.; Liu, J. Evaluation of the protective efficacy of a
commercial vaccine against different antigenic groups of H9N2 influenza viruses in chickens. Vet. Microbiol.
2012, 156, 193–199. [CrossRef] [PubMed]
43. Shahar, E.; Haddas, R.; Goldenberg, D.; Lublin, A.; Bloch, I.; Bachner Hinenzon, N.; Pitcovski, J. Newcastle
disease virus: Is an updated attenuated vaccine needed? Avian Pathol. 2018, 47, 467–478. [CrossRef]
44. Elhady, M.A.; Ali, A.; Kilany, W.H.; Elfeil, W.K.; Ibrahim, H.; Nabil, A.; Samir, A.; El Sayed, M. Field Efficacy
of an Attenuated Infectious Bronchitis Variant 2 Virus Vaccine in Commercial Broiler Chickens. Vet. Sci.
2018, 5, 49. [CrossRef]